entertainment -WSS

entertainment

author：fashion 2025-09-07 14:03:23 - browse：2

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： What happened to the House vote on health price transparency?

WSS

What happened to the House vote on health price transparency?

HHS's proposed rule does nothing to address the climate crisis

Crowdfunding for medical bills sidesteps core problem, author says

Most antidepressants don't work on kids, teens, study finds

FDA panel to weigh safety of artificial wombs for preterm births

GSK’s asthma push continues as drug succeeds in Phase 3 trials

entertainment

entertainment

focus

Medicare proposal to cover medical devices draws a mixed reaction

The creative science of coining drug names

The cancer drug shortage isn’t new — and neither are the solutions

Can gargling with Listerine treat gonorrhea of the mouth?

Walensky prepares to leave CDC — and Congress — behind

The effects of a landmark ruling on DNA ownership are becoming clearer

United colonoscopy coverage change 'may cost lives,' doctors say

Most antidepressants don't work on kids, teens, study finds

Hepatitis C has a cure — but many Americans still lack access to it

Brain technologies pose threats that are all too real, experts warn

hotspot

FDA panel to weigh safety of artificial wombs for preterm births

Why the drug industry's warnings on the IRA's impact fall short

The creative science of coining drug names

People with substance use disorder deserve online privacy

Chemotherapy before breast cancer surgery might fuel metastasis

Deliver public health messages at the right time

entertainment

Wikipedia

hotspot

leisure time